Company Filing History:
Years Active: 2013-2018
Title: Innovations by Inventor Catherine C Y Chang
Introduction
Catherine C Y Chang is a prominent inventor based in Etna, NH (US). She has made significant contributions to the field of medical research, particularly in the treatment of neurodegenerative diseases, obesity, metabolic syndrome, and atherosclerosis. With a total of 9 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents is a method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases. This invention features methods for stimulating the clearance of misfolded or aggregated proteins or peptides in microglia or neurons. It aims to treat neurodegenerative diseases associated with such pathology in the brain by selectively inhibiting the expression or activity of Acyl-CoA: Cholesterol Acyltransferase 1, while not affecting Acyl-CoA: Cholesterol Acyltransferase 2. Another significant patent focuses on selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis. This invention provides methods for preventing and treating these related diseases by inhibiting ACAT1 activity or expression in myeloid cells.
Career Highlights
Catherine Chang is affiliated with Dartmouth College, where she conducts her research and develops her innovative methods. Her work is recognized for its potential to address critical health issues that affect a large population.
Collaborations
Some of her notable coworkers include Ta-Yuan Chang and Yohei Shibuya, who contribute to her research efforts and innovations.
Conclusion
Catherine C Y Chang is a trailblazer in her field, with a focus on developing innovative solutions for complex health challenges. Her contributions through her patents reflect her commitment to advancing medical science and improving patient outcomes.